Metagenomi Common Stock Statistics
Share Statistics
Metagenomi Common Stock has 37.38M
shares outstanding. The number of shares has increased by -0.22%
in one year.
| Shares Outstanding | 37.38M |
| Shares Change (YoY) | -0.22% |
| Shares Change (QoQ) | -0.11% |
| Owned by Institutions (%) | 27.98% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 5,960 |
| FTD / Avg. Volume | 1.36% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.73 and the forward
PE ratio is -0.63.
Metagenomi Common Stock's PEG ratio is
-0.06.
| PE Ratio | -1.73 |
| Forward PE | -0.63 |
| PS Ratio | 2.58 |
| Forward PS | 6 |
| PB Ratio | 0.58 |
| P/FCF Ratio | -1.2 |
| PEG Ratio | -0.06 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Metagenomi Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.91,
with a Debt / Equity ratio of 0.19.
| Current Ratio | 6.91 |
| Quick Ratio | 6.91 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | -0.55 |
| Debt / FCF | -0.41 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $258,886.14 |
| Profits Per Employee | $-386,425.74 |
| Employee Count | 202 |
| Asset Turnover | 0.16 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.51M |
| Effective Tax Rate | 6.6% |
Stock Price Statistics
The stock price has increased by -74.68% in the
last 52 weeks. The beta is -0.65, so Metagenomi Common Stock's
price volatility has been lower than the market average.
| Beta | -0.65 |
| 52-Week Price Change | -74.68% |
| 50-Day Moving Average | 1.72 |
| 200-Day Moving Average | 2.52 |
| Relative Strength Index (RSI) | 48.43 |
| Average Volume (20 Days) | 438,298 |
Income Statement
In the last 12 months, Metagenomi Common Stock had revenue of 52.3M
and earned -78.06M
in profits. Earnings per share was -2.36.
| Revenue | 52.3M |
| Gross Profit | 46.89M |
| Operating Income | -88.9M |
| Net Income | -78.06M |
| EBITDA | -83.49M |
| EBIT | -88.9M |
| Earnings Per Share (EPS) | -2.36 |
Full Income StatementBalance Sheet
The company has 27.39M in cash and 45.78M in
debt, giving a net cash position of -18.39M.
| Cash & Cash Equivalents | 27.39M |
| Total Debt | 45.78M |
| Net Cash | -18.39M |
| Retained Earnings | -223M |
| Total Assets | 324.6M |
| Working Capital | 220.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -109.07M
and capital expenditures -3.11M, giving a free cash flow of -112.19M.
| Operating Cash Flow | -109.07M |
| Capital Expenditures | -3.11M |
| Free Cash Flow | -112.19M |
| FCF Per Share | -3 |
Full Cash Flow StatementMargins
Gross margin is 89.66%, with operating and profit margins of -170% and -149.26%.
| Gross Margin | 89.66% |
| Operating Margin | -170% |
| Pretax Margin | -159.81% |
| Profit Margin | -149.26% |
| EBITDA Margin | -159.66% |
| EBIT Margin | -170% |
| FCF Margin | -214.53% |
